These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8725895)

  • 21. Regional metabolic alterations in Alzheimer's disease: an in vitro 1H NMR study of the hippocampus and cerebellum.
    Mohanakrishnan P; Fowler AH; Vonsattel JP; Jolles PR; Husain MM; Liem P; Myers L; Komoroski RA
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B111-7. PubMed ID: 9060968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study.
    Klunk WE; Panchalingam K; Moossy J; McClure RJ; Pettegrew JW
    Neurology; 1992 Aug; 42(8):1578-85. PubMed ID: 1353623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease histologically proven studied by MRI and MRS: two cases.
    Longo R; Giorgini A; Magnaldi S; Pascazio L; Ricci C
    Magn Reson Imaging; 1993; 11(8):1209-15. PubMed ID: 8271908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
    Lazeyras F; Charles HC; Tupler LA; Erickson R; Boyko OB; Krishnan KR
    Psychiatry Res; 1998 May; 82(2):95-106. PubMed ID: 9754452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology.
    Sweet RA; Panchalingam K; Pettegrew JW; McClure RJ; Hamilton RL; Lopez OL; Kaufer DI; DeKosky ST; Klunk WE
    Neurobiol Aging; 2002; 23(4):547-53. PubMed ID: 12009504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Magnetic resonance spectroscopy in schizophrenia].
    Delamillieure P; Constans JM; Fernandez J; Dollfus S
    Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton 1H- and Phosphorus 31P-MR spectroscopy (MRS) in asymptomatic HIV-positive patients.
    Schuettfort G; Hattingen E; Pilatus U; Stephan C; Wolf T; Goepel S; Haberl A; Blasel S; Zanella F; Brodt HR; Bickel M
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19577. PubMed ID: 25394084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.
    Firbank MJ; Harrison RM; O'Brien JT
    Dement Geriatr Cogn Disord; 2002; 14(2):64-76. PubMed ID: 12145453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging.
    Parnetti L; Tarducci R; Presciutti O; Lowenthal DT; Pippi M; Palumbo B; Gobbi G; Pelliccioli GP; Senin U
    Mech Ageing Dev; 1997 Jul; 97(1):9-14. PubMed ID: 9223122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain.
    Komoroski RA; Pearce JM; Mrak RE
    Magn Reson Med; 2008 Mar; 59(3):469-74. PubMed ID: 18306399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common 1H-MRS Characteristics in Patients With Alzheimer's Disease and Vascular Dementia Diagnosed With Kidney Essence Deficiency Syndrome: A Preliminary Study.
    Guo Z; Liu X; Cao Y; Hou H; Chen X; Chen Y; Huang F; Chen W
    Altern Ther Health Med; 2017 May; 23(3):12-18. PubMed ID: 28236618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 31P nuclear magnetic resonance study of the brain in Alzheimer's disease.
    Pettegrew JW; Moossy J; Withers G; McKeag D; Panchalingam K
    J Neuropathol Exp Neurol; 1988 May; 47(3):235-48. PubMed ID: 3367156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer's disease.
    Henigsberg N; Kalember P; Hrabać P; Rados M; Bajs M; Rados M; Kovavić Z; Loncar M; Madzar T
    Coll Antropol; 2011 Jan; 35 Suppl 1():159-62. PubMed ID: 21648328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
    Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
    J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease.
    Moats RA; Ernst T; Shonk TK; Ross BD
    Magn Reson Med; 1994 Jul; 32(1):110-5. PubMed ID: 8084225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations.
    Pettegrew JW; Kopp SJ; Minshew NJ; Glonek T; Feliksik JM; Tow JP; Cohen MM
    J Neuropathol Exp Neurol; 1987 Jul; 46(4):419-30. PubMed ID: 2955082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD; Rai GS
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease.
    Zhong X; Shi H; Shen Z; Hou L; Luo X; Chen X; Liu S; Zhang Y; Zheng D; Tan Y; Huang G; Fang Y; Zhang H; Mu N; Chen J; Wu R; Ning Y
    J Alzheimers Dis; 2014; 40(4):953-66. PubMed ID: 24531156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of donepezil on brain morphometric and metabolic changes in patients with Alzheimer's disease: A DARTEL-based VBM and (1)H-MRS.
    Moon CM; Kim BC; Jeong GW
    Magn Reson Imaging; 2016 Sep; 34(7):1008-16. PubMed ID: 27131829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.